Germany-based Ada Health has gained an extra $30 million in its Series B funding round, making it total at $120 million. The new funds were raised by Farallon Capital, Red River West, Bertelsman Investments and Schroders Capital. Ada Health has announced that Schroders Capital has become the venture’s major investor through a secondary transaction.
Claire Novorol, Daniel Nathrath and Martin Hirsch founded Ada Health in 2011 based out of Berlin. Ada Health is created by healthcare professionals with the aim to unlock new possibilities in personal health. For this, they have collaborated with leading health systems and global non-profit organizations.
Its AI system can understand the user's symptoms and navigate safely from critical conditions. They had received $20 million in Angel round and later gained €2.4 million in grants. They had raised €40 million by Vitruvian Partners.
The funds will be used to accelerate the rapid growth of Ada's enterprise offering and strengthen its presence in the United States. They are also aiming o build on its sophisticated AI capabilities by developing a personalized and curated operating system for preventive health by connecting external data sources in providing the users with actionable and holistic insights that can be leveraged for their personal health journey.